Integrated Wealth Concepts’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Integrated Wealth Concepts’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-16,558	Closed	-$712K	–	1843
2024 Q4	$712K	Buy	16,558 +168	+1%	+$7.64K	0.01%	969
2024 Q3	$727K	Sell	16,390 -1,185	-7%	-$50.7K	0.01%	931
2024 Q2	$699K	Buy	17,575 +973	+6%	+$39.4K	0.01%	907
2024 Q1	$716K	Buy	16,602 +2,169	+15%	+$93.5K	0.01%	893
2023 Q4	$601K	Buy	14,433 +2,079	+17%	+$78.8K	0.01%	916
2023 Q3	$491K	Buy	12,354 +65	+0.5%	+$2.75K	0.01%	987
2023 Q2	$504K	Buy	12,289 +19	+0.2%	+$785	0.01%	979
2023 Q1	$503K	Hold	12,270	–	–	0.01%	854
2022 Q4	$502K	Sell	12,270 -168	-1%	-$6.99K	0.01%	658
2022 Q3	$500K	Buy	12,438 +279	+2%	+$11.9K	0.02%	593
2022 Q2	$511K	Buy	12,159 +1,303	+12%	+$54.6K	0.02%	597
2022 Q1	$491K	Buy	10,856 +2,618	+32%	+$115K	0.02%	578
2021 Q4	$380K	Buy	8,238 +1,354	+20%	+$64.2K	0.01%	685
2021 Q3	$327K	Buy	+6,884	New	+$342K	0.01%	708

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.28% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Integrated Wealth Concepts's XPH Position: Q1 2025 in Review

Integrated Wealth Concepts sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2025, closing a stake of 16,558 shares — an estimated $712K sold.

Integrated Wealth Concepts first reported a position in XPH in Q3 2021 and held it in 14 quarters. The position peaked at $727K in Q3 2024. 70 funds tracked by Wall St. Rank hold XPH as of Q1 2025.

Integrated Wealth Concepts reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2025 after selling out during the quarter.
Integrated Wealth Concepts sold 16,558 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2025, an estimated $712K.
Integrated Wealth Concepts first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2021 and held it in 14 quarters.
Integrated Wealth Concepts's State Street SPDR S&P Pharmaceuticals ETF position peaked at $727K in Q3 2024.
70 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2025.

Based on Integrated Wealth Concepts's 13F filing for Q1 2025, filed 15 May 2025.